Harbor Capital Advisors’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-9,220
Closed -$592K – 1261
2026
Q1
$592K Sell
9,220
-1,798
-16% -$164K 0.05% 453
2025
Q4
$1.43M Buy
11,018
+1,718
+18% +$236K 0.11% 252
2025
Q3
$1M Sell
9,300
-30,679
-77% -$3.34M 0.08% 321
2025
Q2
$3.69M Buy
39,979
+24,042
+151% +$1.89M 0.16% 202
2025
Q1
$1.41M Buy
+15,937
New +$1.38M 0.06% 359

Other funds holding WGS

Harbor Capital Advisors's WGS Position: Q2 2026 in Review

Harbor Capital Advisors sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 9,220 shares — an estimated $592K sold.

Harbor Capital Advisors first reported a position in WGS in Q1 2025 and held it in 5 quarters. The position peaked at $3.69M in Q2 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Harbor Capital Advisors reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 9,220 GeneDx Holdings shares in Q2 2026, an estimated $592K.
  • Harbor Capital Advisors first reported a position in GeneDx Holdings in Q1 2025 and held it in 5 quarters.
  • Harbor Capital Advisors's GeneDx Holdings position peaked at $3.69M in Q2 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.